Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

Higher inflammation markers are linked to more severe alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Dupilumab for skin problems might reactivate hair loss in some patients.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Men with alopecia areata tend to have larger limb and trunk circumferences than healthy men.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Ayurvedic treatment effectively manages alopecia areata with fewer side effects and relapses.

Salmon patches on the neck may relate to the severity and recurrence of alopecia areata.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.